DAPAVEL GM 10/2/1000MG (Dapagliflozin (10mg) + Glimepiride (2mg) + Metformin (1000mg))

Dapavel-GM 10/2/1000 mg Tablets are indicated for managing Type II Diabetes Mellitus, a chronic condition that affects how the body metabolizes glucose. This type of diabetes can arise from insulin resistance or inadequate insulin production. Each tablet contains a combination of three active ingredients: Dapagliflozin, which belongs to a class of medications known as sodium-glucose cotransporter-2 inhibitors; Metformin, a member of the biguanide class; and Glimepiride, which is categorized as a sulfonylurea. These components collectively function by enhancing the body’s ability to lower elevated blood sugar levels through various mechanisms. Patients may experience side effects, including but not limited to nausea, vomiting, abdominal discomfort, headaches, and possible allergic responses. It is important for individuals to consult their healthcare provider if any side effects continue or escalate. The medication should be taken strictly as directed by a healthcare professional. Those with known allergies to any ingredients in Dapavel-GM 10/2/1000 mg Tablets are advised to avoid this treatment. Additionally, it is imperative to disclose all medications, including herbal supplements, to the healthcare provider prior to initiation of therapy. Pregnant or breastfeeding individuals should inform their doctor before starting this medication. Use in children under 18 years is not recommended.